Woman in a lab

Stop MS Appeal Board

Our Stop MS Board members are critical to the success of our plans. They drive forward our fundraising ambitions through their leadership and advice.
Pod image
Through a programme of research and clinical trials funded by a £100m appeal, we can transform the wellbeing, outlook and quality of life for people living with MS. With your help, we can stop MS. Mark Wood

Stop MS Board members

Mark Wood head shot

Mark Wood

Private Equity Chairman and Investor

Mark, has held several senior positions in global institutions, including Global Head of Cash Management at Barclays Bank, Chief Executive of Prudential UK and Europe, AXA UK, AA, MAI and B&C. In 2006, with £500m of private equity backing, Mark founded Paternoster, which quickly became the market leader in Pension Bulk Annuities. The business was acquired by Goldman Sachs in 2010. Mark chairs PensionBee, Digitalis, RAC Financial Services, Acquis Insurance, Utility Bidder, and Leakbot.

Until 2019, Mark was Chairman of the Board of Trustees of the NSPCC.

Photo shows Kate Hely Hutchinson smiling to camera outside against a blue sky

Kate Hely-Hutchinson
Deputy Chair

UK Private Banker, Citi Private Bank

Kate formerly ran her own company, the DD Bag Company, manufacturing bespoke bags and seating.

She used to work in corporate finance at Nomura International covering major UK businesses and banks, structuring bond finance and equity-related transactions and Tokyo stock exchange listings.

Kate's husband Nick has progressive MS. She was Chair of the Steering Group that developed the vision for our Stop MS Appeal Board.

Photo shows Stop MS Appeal Board Deputy Chair  David Bell wearing a suit in an office setting

Sir David Bell
Board Member

Non-Executive Director, The Economist

Knighted for his longstanding services to industry, the arts and charity, Sir David is a non-executive director of The Economist, former director of Pearson plc and former Chair and Chief Executive of the Financial Times.
Sir David’s involvement in public life and service spans many years, and he is currently the President of Coram. He is Chair of the Cambridge University Press and Roehampton University, of the charities Transformation Trust, Rare Recruitment and Bath Mozartfest. 

Photo shows Stop MS Appeal Board member Iain Conn

Iain Conn
Board Member

Iain held the position of Group Chief Executive of Centrica plc for around 7 years

He was previously BP's Chief Executive, Downstream, and was a board member from 2004-2014. He also served as a non-executive director and senior independent director of Rolls-Royce Holdings plc.

Iain is a non-executive director of BT Group plc, Chairman of the Advisory Board of Imperial College Business School, a member of the advisory board of the Centre for European Reform, a member of the European Round Table of Industrialists.

Photo shows Stop MS Appeal Board member Josh Krichefski hands clasped looking to camera in an office

Josh Krichefski
Board Member

Chief Executive Officer and Global Chief Operating Officer, MediaCom EMEA

Josh Krichefski is CEO of MediaCom EMEA, previously CEO of MediaCom UK. He is responsible for developing and delivering MediaCom EMEA's business goals and future-proofing the business.

Josh was previously MediaCom’s COO for the EMEA region where he worked with the company’s local market teams. Before joining MediaCom Josh was Global Director of Client Development at Havas Digital. He is also a trustee of The Transformation Trust and Futureversity, both of which work with children from deprived backgrounds.

Photo shows Stop MS Appeal Board member Sir Peter Middleton in a suit against an office background

Sir Peter Middleton
Board Member

Chairman, Burford Capital, Burford Capital Holdings (UK) Ltd, Hume Capital Securities Ltd. Founder and Senior Partner, Hamilton Ventures

Sir Peter Middleton is Chairman of Burford Capital, Burford Capital Holdings (UK) Ltd, and Hume Capital Securities Ltd, and Founder and Senior Partner of Hamilton Ventures. He is also Chancellor of the University of Sheffield and a Trustee of the Philharmonia Orchestra.
Sir Peter was Group Chairman of Barclays Bank from 1999-2004, President of the British Bankers Association from 2004-2006 and a member of the National Institute for Economic Research from 1996-2007.

Peter Phillips

Peter Phillips
Board Member

Chief Executive of Cambridge University Press

Peter studied Mathematics at Merton College, Oxford, going on to join the consulting firm Bain & Company and then investment bank SG Warburg. In 1993 he joined the BBC as Head of Corporate Planning, becoming their Director of Business Development in 2005.

In 2006 Peter joined Ofcom as a board member and partner of Strategy & Market Developments. In 2010, he moved to Cambridge University Press and in 2012 he was appointed as their Chief Executive. Peter is also President of the Publishers Association.

Will Pritchett

Will Pritchett
Board Member

Group Chief Information Officer, Royal London Group

Will Pritchett joined Royal London in January 2020 as Group Chief Information Officer with responsibility for technology, change and digital.

Will has worked in Financial Services technology for over 20 years having joined from KPMG where he was Partner for Technology. He has also been a Senior Executive in Accenture and Royal Sun Alliance and has worked globally transforming technology estates.

Photo shows Stop MS Appeal Scientific Ambassador Alan Thompson MD

Professor Alan Thompson MD
Board member

Garfield Weston Professor of Clinical Neurology and Neurorehabilitation at the UCL Institute of Neurology

Professor Alan Thompson is Dean of the Faculty of Brain Sciences at University College London, Garfield Weston Professor of Clinical Neurology and Neurorehabilitation at the UCL Institute of Neurology, a consultant neurologist at the National Hospital for Neurology and Neurosurgery, Queen Square, and Chair of the UCL Partners.

Alan is, amongst other positions, chair of the Scientific Committee of the International Progressive MS Alliance, Chairman of the International Medical and Scientific Board of the Multiple Sclerosis International Federation (MSIF).

Photo shows Stop MS Appeal Board Board member Sir David Walker in a suit in his office

Sir David Walker
Board member

Former Non-Executive Chairman, Winton Capital Management

Sir David Walker was the Non-Executive Chairman of Winton Capital Management from 2015 to 2019. Prior to that, he was Chairman of Barclays from 2012 to 2015 and Chairman and CEO of Morgan Stanley International.

Sir David began his career at HM Treasury, where he served until 1977. He was Chairman of the Securities & Investment Board and, ex officio, a nominated member of the Council of Lloyd’s. Sir David was a non-executive member of the Court of the Bank of England, a non-executive board member of the former CEGB and subsequently of National Power plc.

Jonathan Yates

Jonathan Yates
Board member

Chairman, Monument Re

Jonathan is a Fellow of the Institute of Actuaries with over 35 years’ experience in the life insurance industry. In 2016, he co-founded and now chairs Monument Re, a life insurance and reinsurance group based in Bermuda. He was previously CEO of Windsor Life and, subsequently, Guardian Assurance and also Group Finance Director of Phoenix Group Holdings plc, a UK-listed insurance and asset management company.

Jonathan has previously held non-Executive Directorships with Paternoster Insurance in the UK and The Empire Life Insurance Company in Canada. He is currently a non-Executive Director with the Viridium Group in Germany.

Head shot of Robbert Zoet


Robbert Zoet
Board Member

Head of Capital Markets, Moorfield Group

Robbert has been in Financial Services for over 30 years and is currently Head of Capital Markets at Moorfield. Prior to joining Moorfield he worked at Morgan Stanley, JPMorgan and Lombard Odier.

Robbert is a board member at the Birds Hill Oxshott Estate Company as well as a School Governor at the Royal Kent School in Oxshott. He was involved as a board member of the London City Swim, with the aim to raise awareness and funds directed at research and clinical trials to help find a cure for Motor Neurone Disease (MND).

Photo shows Stop MS Appeal Board Ex officio Board member Nick Winser wearing a suit against a white background

Nick Winser

Non-Executive Director, Kier Group plc, Chair of Trustees, MS Society

Before becoming Chair, Nick became a Trustee at the start of 2015 and Vice-Chair in January 2016. His career has been devoted to the energy sector, primarily working for the National Grid. He is a Non-Executive Director of Kier plc and the Deputy President of the Institution of Engineering and Technology, and also a Trustee of Mid-Warwickshire MenCap.

Nick’s awareness of MS began when his wife, Denise, was diagnosed with the condition in 1999. He has witnessed many of the challenges that come with MS.

Head shot of Nick Moberly

Nick Moberly

Chief Executive, MS Society

Nick joined us in early 2019, at a time of great opportunity for people affected by MS, both in terms of the help we can provide, and our work to stop the progression of MS.

Nick has a wealth of experience in leadership and the health sector, with a strong background in the NHS. His last two roles have been as CEO, most recently at King’s College Hospital NHS Foundation Trust. Before that he was CEO at Royal Surrey County Hospital NHS Foundation Trust for nine years.

Nick is also a trustee of Christian Aid, joining the charity in 2018.

Photo shows Stop MS Appeal Executive Board member Emma Whitcombe against a white background

Dr Emma Whitcombe

Executive Director of Engagement and Income Generation, MS Society

Dr Emma Whitcombe is our Executive Director of Engagement and Income Generation. She was previously Director of Senior Relationships at the National Autistic Society, and held senior fundraising roles at Save the Children, Cystic Fibrosis Trust and Marie Curie Cancer Care.

Emma has developed and led award-winning major gift programmes and appeals, as well as recruiting high profile Development Boards. She holds a PhD in Developmental Psychology and was a Research Fellow at the University of Sussex.

The next research breakthrough is in reach

Your donation will help stop MS.

  • Please enter an amount

    Our minimum donation is £2, please enter a different amount.

£30could process one blood sample, giving researchers crucial information about genes and the immune system.

£50could pay for an hour on a microscope, so scientists can study cells and tissue in greater detail and improve their understanding of the biology of MS.

£100could pay for half an hour of MRI use, so researchers can monitor the success of clinical trials and understand MS in more detail.

Every penny you give really does take us a step closer to stopping MS. Your donation will make a difference.

  • Please enter an amount

    Our minimum donation is £2, please enter a different amount.

£10a month could help cover the cost of a MS Helpline call with our specialist MS Nurse

£20a month could help people with MS get vital support from our Benefits Advisor

£30a month for a year could pay for a day on the MS Helpline, helping people in our MS community

Your regular donation means we can be there for everyone with MS. So no one has to face this pandemic alone.

MS researcher at work in lab, using a pipette